We’re on a mission to develop novel therapies for SCN2A—join us
Community News
This page is dedicated to keeping you up to date on the latest SCN2A news and studies. Here you will be able to explore the latest articles, contribute to community posts, read other people’s stories, and much more.
Sep 06, 2022
SCN2A Patient Community Webinar
We hosted an SCN2A Patient Community Webinar to explore our epilepsy programs PRAX222 and PRAX562 for SCN2A disorders.
Read More >Aug 19, 2022
Praxis SCN2A Live Program Update Webinar
Register Now: Praxis SCN2A Live Program Update Webinar on August 30, 2022, 6pm EDT
Read More >Aug 19, 2022
Connecting for Change Updates For the Rare Epilepsy Community (Summer 2022)
At Praxis Precision Medicines, we have a passion for developing new medicines for genetic epilepsy patients. We have two potential medicines for early onset SCN2A-Developmental Epileptic Encephalopathy (DEE) in clinical study planning phase.
Read More >Feb 23, 2022
SCN2A Awareness Day
International SCN2A Awareness Day is honored on 2/24 because the SCN2A gene is found on chromosome 2 at position 24.3.
Read More >Feb 16, 2022
SCN2A December Community Discussion
At Praxis, we're on a mission to develop novel therapies for SCN2A. We have compiled some questions we have received from you, along with our responses, to keep you informed on our journey. Additionally, we’re pleased to share some preliminary data around Ciitizen, an online platform that allows patients and caregivers an opportunity to advance research.
Read More >Feb 04, 2022
International SCN2A Observational Study Closes 31 January 2022
Praxis would like to thank all the families who participated in the International SCN2A Observational Study.
Read More >Jan 05, 2022
Connecting for Change – Updates For the Rare Epilepsy Community (December 2021)
As we close out 2021, please accept our heartfelt thanks to you — the patients, parents, caregivers, and advocates who guide our work at Praxis. We are truly grateful to have you as partners as we travel together on the path of drug discovery and development. We recognize that behind every data point, is a person, an experience, and a voice — thank you for inspiring us with yours. Wishing you happiness and health in the new year.
Read More >Oct 06, 2021
SCN2A Community Questions
At Praxis, we’re on a mission to develop novel therapies for SCN2A. We believe collaboration with the SCN2A community is critical in this work. We have compiled some questions we have received from you, along with our responses, to keep you informed on our journey.
Read More >
